Showing results (101-110 of 282) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2018
Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive LeukemiasMichael W Schmitt, Justin R Pritchard, Scott M Leighow, et al.
Leukemia Research|January 29, 2016
Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patientsNicholas J Achille, Megan Othus, Kathleen Phelan, et al.
Blood|August 17, 2006
Clinical implications of FLT3 mutations in pediatric AMLSoheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.
The New England Journal of Medicine|October 10, 2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemiaTim P Hughes, Jaspal Kaeda, Susan Branford, et al.
Scientific Reports|April 7, 2022
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarkerDeepti Reddi, Brandon W Seaton, David Woolston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results databaseJohn J Strouse, Thomas R Fears, Margaret A Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2016
Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial DesignFabian Müller, Tyler Cunningham, Xiu Fen Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell TransplantationMatthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Pageof 29